Skip to content

Comparison of Outcome of Injection Sclerotherapy Versus Rubber Band Ligation for Second Degree Hemorrhoids

Comparison of Outcome of Injection Sclerotherapy Versus Rubber Band Ligation for Second Degree Hemorrhoids

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07199673
Enrollment
128
Registered
2025-09-30
Start date
2025-07-07
Completion date
2026-04-06
Last updated
2026-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoid

Keywords

Injection Sclerotherapy, Rubber Band Ligation, Second Degree Hemorrhoids

Brief summary

Objective of this study is to compare the outcome of Injection Sclerotherapy versus Rubber Band Ligation for second degree hemorrhoids in terms of bleeding and efficacy.

Detailed description

There is a difference in the outcome of Injection Sclerotherapy versus Rubber Band Ligation for second degree hemorrhoids in terms of bleeding and efficacy.

Interventions

identifying the hemorrhoidal pedicle, 3-5 ml of 5% phenol in almond oil is injected into the submucosal plane of the hemorrhoid pedicle

knee-elbow position is used. After identifying the hemorrhoids with a proctoscope, a rubber band is applied at the base of each hemorrhoid using Barron's Gun and Elise's tissue forceps.

Sponsors

Gulab Devi Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged between 18 and 75 who have been diagnosed with second-degree hemorrhoids

Exclusion criteria

* Patients with thrombosed hemorrhoids, and those with serious comorbid conditions such as heart, kidney, or liver diseases, coagulation disorders, or severe anemia. * Individuals who have received treatment for hemorrhoids in the past six months. * Pregnant women. * Patients unable to commit to necessary follow-up appointments. * Patients with a history or current presence of colorectal cancer or anal malignancy.

Design outcomes

Primary

MeasureTime frameDescription
Early per rectal Bleeding24 hourswithin 24 hours post-procedure

Secondary

MeasureTime frameDescription
Delayed Bleeding Per rectal24 hours to 14th post operative day24 hours to 14th post-operative day

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026